Date published: 2025-11-24

00800 4573 8000

SCBT Portrait Logo
Seach Input

IRG1 Activateurs

The chemical class designated as IRG1 Activators encompasses a diverse group of compounds that share the common function of inducing the expression of the immune-responsive gene 1 (IRG1) protein. These molecules are of particular interest due to their ability to engage with and modulate the immune system's metabolic pathways. IRG1 activators can be found in a variety of sources, including natural substances found in plants, synthetic compounds designed to mimic pathogenic components, and even metabolic byproducts. The primary unifying characteristic of these activators is their capacity to stimulate the cellular mechanisms that lead to the upregulation of IRG1, a key player in the immune response to environmental challenges. While their structures and origins are varied, the outcome of their interaction with immune cells converges on the enhancement of itaconate production, a metabolite significant for its role in immune cell function.

The mechanisms through which IRG1 activators exert their influence are multifaceted and interconnected with the core signaling pathways of immune cells. For instance, some activators function by mimicking the presence of pathogens, engaging toll-like receptors (TLRs) and triggering a defensive cellular response that includes the upregulation of IRG1. Others may interact with cellular pathways that control the transcriptional machinery, leading to increased expression of the IRG1 gene. The actions of these compounds are often associated with alterations in the cellular redox state, modulation of inflammatory responses, and the reprogramming of cellular metabolism. Despite the different molecular pathways they affect, IRG1 activators collectively contribute to the dynamic regulation of immune responses, illustrating the profound impact that small molecules can have on the complex network of immune regulation. Through their interaction with cellular processes, these activators provide valuable insights into the intricate balance between metabolic and immune system dynamics.

VOIR ÉGALEMENT...

Nom du produitCAS #Ref. CatalogueQuantitéPrix HTCITATIONS Classement

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$96.00
$166.00
$459.00
$1615.00
12
(2)

Induit l'activation des macrophages et la production subséquente de cytokines, ce qui peut entraîner la régulation à la hausse de l'IRG1.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

A des effets immunomodulateurs et peut activer la signalisation Nrf2, affectant potentiellement l'expression de l'IRG1.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Modifie la voie NF-κB, qui est impliquée dans l'expression d'un large éventail de gènes de réponse immunitaire, y compris peut-être IRG1.

Metformin-d6, Hydrochloride

1185166-01-1sc-218701
sc-218701A
sc-218701B
1 mg
5 mg
10 mg
$286.00
$806.00
$1510.00
1
(1)

Affecte le métabolisme des macrophages et a des effets anti-inflammatoires, ce qui pourrait indirectement augmenter l'IRG1.

Gardiquimod

1020412-43-4sc-221663
sc-221663A
sc-221663B
sc-221663C
sc-221663D
sc-221663E
sc-221663F
25 mg
50 mg
100 mg
250 mg
5 g
10 g
25 g
$154.00
$276.00
$506.00
$1154.00
$19743.00
$32136.00
$69366.00
1
(1)

Agoniste TLR7 qui peut activer les réponses immunitaires, en régulant éventuellement IRG1 dans le cadre de cette réponse.

Imiquimod

99011-02-6sc-200385
sc-200385A
100 mg
500 mg
$66.00
$278.00
6
(1)

Agoniste TLR7/8 qui active les réponses immunitaires innées, augmentant potentiellement l'expression de l'IRG1.

Pam3Cys-Ser-(Lys)4, Hydrochloride

112208-00-1sc-507471
2 mg
$550.00
(0)

Agoniste TLR1/2 qui peut déclencher l'activation des cellules immunitaires, entraînant potentiellement une augmentation de l'expression de l'IRG1.